Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bi-weekly cetuximab + FOLFOX-6 as first-line treatment in metastatic colorectal cancer (KRAS wild-type)
2007-000460-24Phase 2Completed
- Sponsor
- University of Duisburg-Essen
- Start
- Nov 2008
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cetuximab in colorectal cancer (CRC), sponsored by University of Duisburg-Essen. Primary endpoints: Objective response rate and Safety. Started Nov 2008; status: completed.
02
Drugs
cetuximab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2007-000460-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000460-24.